(Total Views: 269)
Posted On: 08/20/2021 12:58:33 PM
Post# of 1354
$PBIO 8k & Investor Presentation
SEC Form 8k Link: https://www.sec.gov/ix?doc=/Archives/edgar/da...orm8-k.htm
Investor Presenation Link: https://www.sec.gov/Archives/edgar/data/83065...ex99-1.htm
Item 7.01 Regulation FD Disclosure.
Effective August 18, 2021, executives of Pressure BioSciences, Inc. (the “Company”) have begun using the materials included in Exhibit 99.1 to this report (the “Investor Presentation”) in connection with presentations to existing stockholders of the Company, potential investors of the Company, and the investment community. The Investor Presentation provides an overview of the Company’s strategy, performance and future objectives.
The information provided under this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is “furnished” and shall not be deemed “filed” with the Securities and Exchange Commission or incorporated by reference in any filing under the Securities Exchange Act or 1934 or the Securities Act of 1933.
SEC Form 8k Link: https://www.sec.gov/ix?doc=/Archives/edgar/da...orm8-k.htm
Investor Presenation Link: https://www.sec.gov/Archives/edgar/data/83065...ex99-1.htm
Item 7.01 Regulation FD Disclosure.
Effective August 18, 2021, executives of Pressure BioSciences, Inc. (the “Company”) have begun using the materials included in Exhibit 99.1 to this report (the “Investor Presentation”) in connection with presentations to existing stockholders of the Company, potential investors of the Company, and the investment community. The Investor Presentation provides an overview of the Company’s strategy, performance and future objectives.
The information provided under this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is “furnished” and shall not be deemed “filed” with the Securities and Exchange Commission or incorporated by reference in any filing under the Securities Exchange Act or 1934 or the Securities Act of 1933.
(0)
(0)
